This article is more than 5 years old. Information may no longer be current.

OSN’s top news of the week

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Here are the top stories on Healio.com/OSN this past week:

FDA approves Dextenza for treatment of postoperative ocular pain

Dextenza (dexamethasone ophthalmic insert 0.4 mg) is the first FDA-approved intracanalicular insert to deliver dexamethasone to treat postoperative ocular pain for up to 30 days with one treatment. Read more.

IND application accepted for CRISPR genome editing treatment for LCA10

The FDA has accepted an investigational new drug application for Editas Medicine’s experimental CRISPR genome editing medicine for the treatment of Leber congenital amaurosis type 10. Read more.

FDA clears IND application for ProQR’s Usher syndrome treatment

QR-421a, an investigational RNA-based oligonucleotide, addresses the underlying cause of vision loss in Usher syndrome type 2 and non-syndromic retinitis pigmentosa due to mutations in exon 13 of the USH2A gene. Read more.

EyeMax Mono IOL shows promise in patients with macular disease

Visual acuity improved in patients with geographic atrophy who underwent cataract surgery and implantation of a novel monofocal IOL in the capsular bag, according to a study. Read more.

Small aperture corneal inlay may offer alternative in pseudophakic patients

Cataract surgery patients who underwent implantation of monofocal IOLs in combination with a small aperture corneal inlay in the nondominant eye experienced improved intermediate and near visual acuity compared with patients who underwent conventional cataract surgery. Read more.